Inventor · disambiguated record
Lynn Hawkins
Also filed as: HAWKINS LYNN · HAWKINS LYNN D
35 granted patents·10 pending applications·620 citations·filing 1988–2023
97Inventor score
Top patents by PatentIndex Score
45 records- 0197US9428495B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted Aug 30, 2016·35 cites·32 claims
- 0297US4971959ATrisubstituted phenyl analogs having activity for congestive heart failureWARNER LAMBERT CO·Filed 1988·Granted Nov 20, 1990·67 cites·11 claims
- 0396US5274002ATrisubstituted phenyl analogs having activity for congestive heart failureWARNER LAMBERT CO·Filed 1990·Granted Dec 28, 1993·69 cites·40 claims
- 0493US9126999B2Tetrahydropyrazolopyrimidine compoundsBOIVIN ROCH·Filed 2013·Granted Sep 8, 2015·33 cites·28 claims
- 0590US9446046B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2015·Granted Sep 20, 2016·8 cites·6 claims
- 0690US7550501B2Compounds and methods for treating toll-like receptor 2-related diseases and conditionsEISAI R&D MAN CO LTD·Filed 2007·Granted Jun 23, 2009·18 cites·34 claims
- 0790US6551600B2Immunological adjuvant compounds compositions and methods of use thereofEISAI CO LTD·Filed 2001·Granted Apr 22, 2003·37 cites·16 claims
- 0890US6521776B2Immunological adjuvant compounds compositions and methods of use thereofEISAI CO LTD·Filed 2001·Granted Feb 18, 2003·29 cites·16 claims
- 0990US6290973B1Immunological adjuvant compounds, compositions, and methods of use thereofEISAI CO LTD·Filed 2000·Granted Sep 18, 2001·64 cites·13 claims
- 1088US7683200B2Compounds for preparing immunological adjuvantEISAI R&D MAN CO LTD·Filed 2006·Granted Mar 23, 2010·11 cites·11 claims
- 1186US6835721B2Immunomodulatory compounds and methods of use thereofEISAI CO LTD·Filed 2002·Granted Dec 28, 2004·22 cites·36 claims
- 1285US5530113AAnti-endotoxin compoundsEISAI CO LTD·Filed 1992·Granted Jun 25, 1996·72 cites·20 claims
- 1384US7202234B2Compounds and methods for treating Toll-like receptor 2-related diseases and conditionsEISAI CO LTD·Filed 2004·Granted Apr 10, 2007·18 cites·35 claims
- 1483US10640500B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted May 5, 2020·1 cites·5 claims
- 1583US9850242B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2016·Granted Dec 26, 2017·3 cites·12 claims
- 1683US5756718AAnti-endotoxin compoundsEISAI CO LTD·Filed 1995·Granted May 26, 1998·47 cites·3 claims
- 1782US7976852B2Compositions and methods for cancer immunotherapyEISAI R&D MAN CO LTD·Filed 2006·Granted Jul 12, 2011·2 cites·27 claims
- 1879US8198474B2Compounds for preparing immunological adjuvantFANG FRANCIS G·Filed 2010·Granted Jun 12, 2012·4 cites·20 claims
- 1979US7560584B2Immunomodulatory compounds and methods of use thereofEISAI R&D MAN CO LTD·Filed 2004·Granted Jul 14, 2009·8 cites·1 claims
- 2078US5612476AAnti-endotoxin compoundsEISAI CO LTD·Filed 1995·Granted Mar 18, 1997·36 cites·6 claims
- 2177US5843918AAnti-endotoxin compoundsEISAI CO LTD·Filed 1995·Granted Dec 1, 1998·30 cites·1 claims
- 2275US8519170B2Compounds for preparing immunological adjuvantFANG FRANCIS G·Filed 2012·Granted Aug 27, 2013·2 cites·6 claims
- 2373US7838548B2Compounds and methods for treating toll-like receptor 2-related diseases and conditionsEISAI R&D MAN CO LTD·Filed 2009·Granted Nov 23, 2010·1 cites·7 claims
- 2473US7833993B2Immunomodulatory compounds and methods of use thereofEISAI R&D MAN CO LTD·Filed 2005·Granted Nov 16, 2010·1 cites·12 claims
- 2570US11130758B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2020·Granted Sep 28, 2021·0 cites·9 claims
- 2667US9663486B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted May 30, 2017·1 cites·14 claims
- 2765US8962857B2Compounds for preparing immunological adjuvantEISAI R&D MAN CO LTD·Filed 2014·Granted Feb 24, 2015·0 cites·3 claims
- 2865US2014065100A1Compositions and Methods for Cancer ImmunotherapyEISAI R&D MAN CO LTD·Filed 2013·Application pending·0 cites
- 2964US2018354939A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 3063US8754236B2Compounds for preparing immunological adjuvantEISAI R&D MAN CO LTD·Filed 2013·Granted Jun 17, 2014·0 cites·2 claims
- 3162USRE47193ESelectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted Jan 8, 2019·0 cites·32 claims
- 3262US10087174B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted Oct 2, 2018·0 cites·17 claims
- 3362US2007292418A1Compositions and methods for immunotherapyEISAI CO LTD·Filed 2006·Application pending·0 cites
- 3462US2025313574A1Sialic acid derivatives and methods of using sameEISAI R&D MAN CO LTD·Filed 2023·Application pending·0 cites
- 3561US7919643B2Reagents and methods for the beta-keto amide synthesis of a synthetic precursor to immunological adjuvant E6020EISAI R&D MAN CO LTD·Filed 2008·Granted Apr 5, 2011·0 cites·19 claims
- 3660US7524883B2Eponemycin and epoxomicin analogs and uses thereofEISAI R&D MAN CO LTD·Filed 2003·Granted Apr 28, 2009·1 cites·52 claims
- 3760US2016326161A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2016·Application pending·0 cites
- 3856US8049023B2Reagents and methods for the beta-keto amide synthesis of a synthetic precursor to immunological adjuvant E6020EISAI R&D MAN CO LTD·Filed 2010·Granted Nov 1, 2011·0 cites·15 claims
- 3956US2009291998A1Eponemycin and epoxomicin analogs and uses thereofEISAI R&D MAN CO LTD·Filed 2009·Application pending·0 cites
- 4054US7915238B2Immunomodulatory compounds and methods of use thereofEISAI R&D MAN CO LTD·Filed 2006·Granted Mar 29, 2011·0 cites·11 claims
- 4154US2023149537A1Vaccines, adjuvants, and methods of generating an immune responseEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 4252US8603482B2Compositions and methods for cancer immunotherapyROSSIGNOL DANIEL P·Filed 2011·Granted Dec 10, 2013·0 cites·12 claims
- 4352US2011243935A1Compositions and Methods for ImmunotherapyEISAI R&D MAN CO LTD·Filed 2011·Application pending·0 cites
- 4451US2011130349A1Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and ConditionsCHOW JESSE·Filed 2010·Application pending·0 cites
- 4548US2004006242A1Immunomodulatory compounds and method of use thereofFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →